Get started
AstraZeneca PLCAstraZeneca PLCAstraZeneca PLC

AstraZeneca PLC

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast Bonds

AZN chart


Full chart

Key facts today

AstraZeneca's Calquence, a BTK inhibitor launched in 2017, competes with BeiGene's Brukinsa from 2019. The BTK inhibitor market is expected to grow significantly.
Analyze the impactAnalyze the impact

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪244.11 B‬USD
Dividend yield (indicated)
1.85%
Price to earnings Ratio (TTM)
37.92
Basic EPS (TTM)
2.08USD
Net income (FY)
‪5.96 B‬USD
Revenue (FY)
‪45.81 B‬USD
Shares float
‪3.10 B‬
Beta (1Y)
0.41

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Employees (FY)
‪89.9 K‬
Founded
1992
FIGI
BBG000BZ0DK8
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Highest yielding bonds


US46353AM0
ASTRAZENECA PLC 15/45
US46353AU2
ASTRAZENECA 18/48
ZEGB
ASTRAZENECA PLC 12/42
AZN.GE
AstraZeneca 6.45% 15-SEP-2037
US46353AZ1
ASTRAZENECA 21/51
US46353AX6
ASTRAZENECA 20/50
A
US4636NAN3
ASTRAZEN.FI. 24/34
US46353AL2
ASTRAZENECA PLC 15/25
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
50UC
ASTRAZENECA PLC 5.75% SNR EMTN 13/11/2031
A
US4636NAM5
ASTRAZEN.FI. 24/31

Explore more bonds 

Sparks


Curated watchlists where AZN is featured.

See all sparks